STOCKHOLM, Oct. 24, 2024 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the third quarter 2024 Third Quarter 2024 Total revenue increased 33 per cent, 39 per cent at constant exchange rates, (CER)1, to SEK 6,894 M (5,168) Haematology revenue...
Sobi Q3 2024 report: Strong growth and significant pipeline momentum
Seaking AlphaSeeking Alpha / Seaking Alpha 3 hours ago 1 Views
Comments